The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2022 | Remaining questions and future directions following the Yorkshire Enhanced Stop Smoking Study
Rachael Murray, PhD, FRCR, MRCP, MB ChB, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, talks on future directions and remaining questions following the results of the Yorkshire Enhanced Stop Smoking Study (YESS) (NCT03750110), including whether there needs to be gender-specific intervention. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.
